Hong-Yue Lai Selected Research

CCAAT-Enhancer-Binding Protein-delta

1/2020	Metformin Resensitizes Sorafenib-Resistant HCC Cells Through AMPK-Dependent Autophagy Activation.
9/2017	CCAAT/enhancer-binding protein delta promotes intracellular lipid accumulation in M1 macrophages of vascular lesions.
2/2017	Metformin promotes apoptosis in hepatocellular carcinoma through the CEBPD-induced autophagy pathway.
11/2015	HMDB and 5-AzadC Combination Reverses Tumor Suppressor CCAAT/Enhancer-Binding Protein Delta to Strengthen the Death of Liver Cancer Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hong-Yue Lai Research Topics

Disease

11	Neoplasms (Cancer) 01/2022 - 11/2015
4	Carcinoma (Carcinomatosis) 01/2022 - 01/2021
4	Rectal Neoplasms (Rectal Cancer) 09/2021 - 01/2021
3	Carcinogenesis 01/2022 - 01/2022
2	Neoplasm Metastasis (Metastasis) 01/2022 - 09/2021
2	Liver Neoplasms (Liver Cancer) 01/2020 - 11/2015
1	Nasopharyngeal Carcinoma 01/2022
1	Gallbladder Neoplasms (Gallbladder Cancer) 01/2021
1	Leukemia 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2017
1	Atherosclerotic Plaque (Atheroma) 09/2017
1	Inflammation (Inflammations) 09/2017
1	Hepatocellular Carcinoma (Hepatoma) 02/2017

Drug/Important Bio-Agent (IBA)

4	CCAAT-Enhancer-Binding Protein-deltaIBA 01/2020 - 11/2015
2	Metformin (Glucophage)FDA LinkGeneric 01/2020 - 02/2017
2	Transcription Factors (Transcription Factor)IBA 09/2017 - 02/2017
1	Cartilage Oligomeric Matrix ProteinIBA 01/2022
1	ForminsIBA 01/2022
1	MetallothioneinIBA 01/2022
1	MetalsIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	CateninsIBA 01/2022
1	Mucin-2IBA 07/2021
1	Indicators and Reagents (Reagents)IBA 07/2021
1	Cathepsin EIBA 07/2021
1	Formaldehyde (Formol)FDA Link 01/2021
1	Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA 01/2021
1	APOBEC-1 DeaminaseIBA 01/2021
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2021
1	Pyruvic Acid (Pyruvate)IBA 01/2021
1	LeptinIBA 01/2021
1	aristolochic acid I (aristolochic acid)IBA 01/2021
1	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 01/2021
1	Gemcitabine FDA Link 01/2021
1	Oxidoreductases (Dehydrogenase)IBA 01/2021
1	ParaffinIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	AMP-Activated Protein KinasesIBA 01/2020
1	Sorafenib (BAY 43-9006)FDA Link 01/2020
1	LipidsIBA 09/2017
1	Apolipoproteins E (ApoE)IBA 09/2017
1	Proteins (Proteins, Gene)FDA Link 09/2017
1	Decitabine FDA Link 11/2015

Therapy/Procedure

4	Chemoradiotherapy 09/2021 - 01/2021
2	Drug Therapy (Chemotherapy) 01/2022 - 09/2021
1	Radiotherapy 01/2022
1	Proctectomy 01/2021